Suppr超能文献

母源性 20 号染色体单亲二体(UPD(20)mat)作为 Silver-Russell 综合征的鉴别诊断:三例新病例的鉴定。

Maternal Uniparental Disomy of Chromosome 20 (UPD(20)mat) as Differential Diagnosis of Silver Russell Syndrome: Identification of Three New Cases.

机构信息

Research Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, 20095 Milan, Italy.

Department of Pediatrics, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.

出版信息

Genes (Basel). 2021 Apr 17;12(4):588. doi: 10.3390/genes12040588.

Abstract

Silver Russell Syndrome (SRS, MIM #180860) is a rare growth retardation disorder in which clinical diagnosis is based on six features: pre- and postnatal growth failure, relative macrocephaly, prominent forehead, body asymmetry, and feeding difficulties (Netchine-Harbison clinical scoring system (NH-CSS)). The molecular mechanisms consist in (epi)genetic deregulations at multiple loci: the loss of methylation (LOM) at the paternal :IG-DMR (chr11p15.5) (50%) and the maternal uniparental disomy of chromosome 7 (UPD(7)mat) (10%) are the most frequent causes. Thus far, about 40% of SRS remains undiagnosed, pointing to the need to define the rare mechanisms in such a consistent fraction of unsolved patients. Within a cohort of 176 SRS with an NH-CSS ≥ 3, a molecular diagnosis was disclosed in about 45%. Among the remaining patients, we identified in 3 probands (1.7%) with UPD(20)mat (Mulchandani-Bhoj-Conlin syndrome, OMIM #617352), a molecular mechanism deregulating the locus and described in 21 cases, characterized by severe feeding difficulties associated with failure to thrive, preterm birth, and intrauterine/postnatal growth retardation. Our patients share prominent forehead, feeding difficulties, postnatal growth delay, and advanced maternal age. Their clinical assessment and molecular diagnostic flowchart contribute to better define the characteristics of this rare imprinting disorder and to rank UPD(20)mat as the fourth most common pathogenic molecular defect causative of SRS.

摘要

Silver Russell 综合征(SRS,MIM #180860)是一种罕见的生长发育迟缓疾病,其临床诊断基于六个特征:产前和产后生长发育不良、相对大头畸形、前额突出、身体不对称和喂养困难(Netchine-Harbison 临床评分系统(NH-CSS))。分子机制包括多个基因座的(表观)遗传调控失调:父系:IG-DMR(chr11p15.5)的甲基化丧失(LOM)(50%)和母系 7 号染色体单亲二倍体(UPD(7)mat)(10%)是最常见的原因。迄今为止,大约 40%的 SRS 仍然无法诊断,这表明需要在如此大比例的未解决患者中定义罕见的机制。在一个 NH-CSS≥3 的 176 名 SRS 患者队列中,约有 45%的患者发现了分子诊断。在其余患者中,我们在 3 名具有 UPD(20)mat 的先证者(Mulchandani-Bhoj-Conlin 综合征,OMIM #617352)中发现了一种分子机制,该机制会调节 基因座,该机制已在 21 例中得到描述,其特征为严重的喂养困难与生长不良、早产和宫内/产后生长迟缓相关。我们的患者具有共同的突出前额、喂养困难、出生后生长延迟和高龄产妇。他们的临床评估和分子诊断流程图有助于更好地定义这种罕见的印迹障碍的特征,并将 UPD(20)mat 列为导致 SRS 的第四种最常见的致病性分子缺陷。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ff/8073552/8750c2728e7d/genes-12-00588-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验